首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3305篇
  免费   237篇
  国内免费   12篇
耳鼻咽喉   34篇
儿科学   163篇
妇产科学   43篇
基础医学   400篇
口腔科学   41篇
临床医学   208篇
内科学   804篇
皮肤病学   106篇
神经病学   281篇
特种医学   57篇
外科学   527篇
综合类   79篇
预防医学   232篇
眼科学   56篇
药学   338篇
中国医学   15篇
肿瘤学   170篇
  2023年   23篇
  2022年   54篇
  2021年   85篇
  2020年   46篇
  2019年   94篇
  2018年   82篇
  2017年   59篇
  2016年   79篇
  2015年   71篇
  2014年   79篇
  2013年   148篇
  2012年   164篇
  2011年   170篇
  2010年   113篇
  2009年   93篇
  2008年   136篇
  2007年   183篇
  2006年   156篇
  2005年   149篇
  2004年   99篇
  2003年   122篇
  2002年   118篇
  2001年   67篇
  2000年   84篇
  1999年   81篇
  1998年   30篇
  1996年   23篇
  1995年   19篇
  1993年   22篇
  1992年   60篇
  1991年   53篇
  1990年   25篇
  1989年   42篇
  1988年   43篇
  1987年   41篇
  1986年   34篇
  1985年   33篇
  1984年   25篇
  1983年   33篇
  1982年   29篇
  1979年   20篇
  1976年   25篇
  1975年   28篇
  1974年   27篇
  1973年   23篇
  1972年   18篇
  1971年   27篇
  1970年   30篇
  1969年   25篇
  1968年   18篇
排序方式: 共有3554条查询结果,搜索用时 0 毫秒
1.
Tofacitinib is an immunosuppressive and disease-modifying therapy in rheumatoid arthritis. It may result in many infections flaring up. It is important to take precautions of all kinds (cardiovascular, malignancy, infections etc.) before starting tofacitinib. In this article, we have highlighted important steps where we need to take precautions before starting tofacitinib.  相似文献   
2.
3.
4.

Background

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.

Methods

Adults aged ≥50 (ZOE-50) and ≥70 (ZOE-70) years were randomly vaccinated with RZV or placebo. Safety analyses were performed on the pooled total vaccinated cohort, consisting of participants receiving at least one dose of RZV or placebo. Solicited and unsolicited adverse events (AEs) were collected for 7 and 30?days after each vaccination, respectively. Serious AEs (SAEs) were collected from the first vaccination until 12?months post-last dose. Fatal AEs, vaccination-related SAEs, and potential immune-mediated diseases (pIMDs) were collected during the entire study period.

Results

Safety was evaluated in 14,645 RZV and 14,660 placebo recipients. More RZV than placebo recipients reported unsolicited AEs (50.5% versus 32.0%); the difference was driven by transient injection site and solicited systemic reactions that were generally seen in the first week post-vaccination. The occurrence of overall SAEs (RZV: 10.1%; Placebo: 10.4%), fatal AEs (RZV: 4.3%; Placebo: 4.6%), and pIMDs (RZV: 1.2%; Placebo: 1.4%) was balanced between groups. The occurrence of possible exacerbations of pIMDs was rare and similar between groups. Overall, except for the expected local and systemic symptoms, the safety results were comparable between the RZV and Placebo groups irrespective of participant age, gender, or race.

Conclusions

No safety concerns arose, supporting the favorable benefit-risk profile of RZV.  相似文献   
5.
6.
7.
A rare case of an advanced primary broad ligament carcinoma is discussed, with a review of the literature regarding its incidence, presentation and management. This patient showed a complete response to adjuvant cisplatin-based chemotherapy following panhysterectomy and is presently without any evidence of disease, 15 months after completion of her treatment.  相似文献   
8.
In a general review, the authors discuss present knowledge on the main protein on the surface of the normal fibroblast, fibronectin. The peculiarities of this glycoprotein (localisation at the level of the cell surface, importance of thiol groups in the structure and expression of certain of its properties, reduction of the cells transformed by oncogenic viruses) are considered. The relationships which they may present with a plasma protein, cold insoluble globulin, are discussed together with the important role which they seem to play in the phenomena of cell adhesiveness.  相似文献   
9.
10.
R B Lal  D L Rudolph 《Blood》1991,78(3):571-574
The human T-cell lymphotropic viruses (HTLV) type I and type II are capable of inducing a variety of cellular genes, including many of the cytokines that regulate cell proliferation. To determine if the spontaneous proliferation of peripheral blood mononuclear cells from patients infected with HTLV-I and HTLV-II was related to coordinate expression of cytokines, we analyzed the levels of interleukin-1 beta (IL-1 beta), IL-2, IL-3, IL-4, IL-6, tumor necrosis factor-alpha (TNF-alpha) and interferon-tau (IFN-tau) in culture supernatants derived from spontaneously proliferating cells. Significantly elevated levels of IL-6 and TNF-alpha were present in culture supernatants from HTLV-I/II-infected individuals when compared with normal controls (P less than .01). Kinetic experiments showed that both IL-6 and TNF-alpha were elevated by day 5. None of the other cytokines (IL-1 beta, IL-2, IL-3, IL-4, and IFN-tau) were detectable in any of the culture. These data suggest that release of IL-6 and TNF-alpha may regulate lymphocyte proliferation in HTLV-I/II-infected individuals.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号